BioSpace News Archive

ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional bioproduct candidates originally derived from proprietary algal cultures, today announced that President & Chief Executive Officer Andrew Dahl will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

Ophthalmic lens technology leader HOYA Vision Care announced the official launch of its highly anticipated Visionary Alliance, a loyalty program designed to meet and exceed the professional needs of independent ECPs through a global knowledge base and business tools, advice, and support to help them to run their business their way - as an independent.

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, announced its raised mid-term business targets for 2025.

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients, regulatory starting materials and advanced intermediates.

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting on June 2nd 2021, at eClinical & Clinical Data Management Innovation Conference.

Healthcare Integrated Technologies, Inc. (“HITC”) is excited to announce the expansion of its strategic partnership with Merrill Gardens Senior Living. HITC will install its innovative SafeSpace™ with AI Vision™ fall detection technology in a second of Merrill Gardens’ seventy-two communities.

CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology platform company targeting calcium release-activated calcium (CRAC) channels for the treatment of severe acute and chronic inflammatory diseases, today announced the publication of results from the Company’s completed randomized, open-label, dose-response Phase 2a study in the peer-reviewed journal Pancreas

Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax’s SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic

Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the Goldman Sachs 42 nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 12:50 pm PT / 3:50 pm ET. Gerrit Klaerner, Tricida’s Founder, President and Chief Executive Officer, will provide a company overview, business update and progress on the company’s key initiatives.

SINOVAC Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that CoronaVac®, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences Co., Ltd. (“SINOVAC”), a subsidiary of the Company, was approved for emergency use under the World Health Organization